New Philadelphia Proton Therapy Center Promises Heavy Research Focus
This article was originally published in The Gray Sheet
Executive Summary
Protons will one day overtake photons as the dominant cancer radiation tool, and research conducted at the new Roberts Proton Therapy Center in Philadelphia will help accelerate the technology's adoption, contends Zelig Tochner, medical director of the facility
You may also be interested in...
Prostate Cancer Radiation Comparisons Support IMRT, Question Proton Therapy
A large Medicare database analysis provides support for intensity-modulated radiation therapy as the standard radiation tool for prostate cancer, while the nascent proton therapy showed no advantages.
ASTRO In Brief
Proton therapy for prostate cancer: Three prospective studies show that radiation with proton beam therapy in prostate cancer patients causes minimal urinary and rectal side effects, according to a Nov. 2 presentation by Nancy Mendenhall, M.D., University of Florida Proton Therapy Institute, at the American Society for Radiation Oncology annual meeting in Chicago. Investigators examined genitourinary and gastrointestinal toxicity scores in 212 proton therapy patients one year post-treatment. Results showed that less than 1% of patients had severe Grade 3 genitourinary side effects and less than one-half percent experienced Grade 3 GI toxicities. In a separate presentation, Carl J. Rossi, M.D., et al., Loma Linda University Medical Center, showed data from a randomized trial concluding men who receive a "boost" of proton therapy after receiving standard X-ray radiation therapy have fewer recurrences of prostate cancer
Data Lacking On Proton Therapy Vs. Traditional Radiation For Cancer - AHRQ
Particle beam radiation - also known as proton therapy - is a "promising" cancer treatment, but potential advantages over alternative radiation therapies remain unproven due to a lack of long-term comparative studies, according to a Sept. 14 Agency for Healthcare Research and Quality technical brief